Drugs & Therapy Perspectives

, Volume 3, Issue 5, pp 9–10 | Cite as

Optimising the use of depot medroxyprogesterone acetate

New Drugs and Therapeutics
  • 4 Downloads

Keywords

Contraceptive Method Griseofulvin DMPA Flucytosine Combine Oral Contraceptive 

References

  1. 1.
    Kaunitz AM, Rosenfield A. Drugs 45: 857–865, 1993PubMedCrossRefGoogle Scholar
  2. 2.
    Depo-Provera® US package insert, Upjohn, 1992Google Scholar
  3. 3.
    British National Formulary 26: 197, 1993Google Scholar
  4. 4.
    Ceulaer K, et al. Lancet 2: 229–231-1982PubMedCrossRefGoogle Scholar
  5. 5.
    Trussell J, Kost K. Stud Fam Plan 18: 237–283, 1987CrossRefGoogle Scholar
  6. 6.
    Siriwongse T, et al. Contraception 26: 487–493, 1982PubMedCrossRefGoogle Scholar
  7. 7.
    Belsey EM. Contraception 38: 181–206, 1988PubMedCrossRefGoogle Scholar
  8. 8.
    Kamau RK, et al. E Afr Med J 61: 550–555, 1990Google Scholar
  9. 9.
    Fahmy K, et al. Contraception 44: 419–430, 1991PubMedCrossRefGoogle Scholar
  10. 10.
    Virutamasen P, et al. Int J Gynecol Obstet 24: 291–296, 1986CrossRefGoogle Scholar
  11. 11.
    Fahmy K, et al. Contraception 44: 431–444, 1991PubMedCrossRefGoogle Scholar
  12. 12.
    Garza-Flores J, et al. Contraception 44: 61–71, 1991PubMedCrossRefGoogle Scholar
  13. 13.
    Oyelola OO. Contraception 47: 445–454, 1993PubMedCrossRefGoogle Scholar
  14. 14.
    Cundy T, et al. BMJ 303: 13–16, 1991PubMedCrossRefGoogle Scholar
  15. 15.
    Cundy T, et al. BMJ 308: 247–248, 1994PubMedCrossRefGoogle Scholar
  16. 16.
    Pardthaisong T. J Biosocial Sci 16: 23–34, 1984Google Scholar

Copyright information

© Adis International Limited 1994

Personalised recommendations